Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1995
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/30/1995CA2166621A1 Azabicycloalkyl derivatives of imidazo(1,5-a)indol-3-one and process for their preparation
11/30/1995CA2166619A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995CA2166617A1 Imidazolylalkyl derivatives of imidazol(5,1-c)(1,4)benzoxazin-1-one and their use as therapeutic agents
11/29/1995EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/29/1995EP0684259A1 L-lysyl-glycyl-L-histidine and therapeutic agent for wound healing containing the same
11/29/1995EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution
11/29/1995EP0684040A2 Skin treatment composition
11/29/1995EP0683817A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof
11/29/1995EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase
11/29/1995EP0683772A1 Retroviral protease inhibiting compounds
11/29/1995EP0683767A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
11/29/1995EP0683670A1 Wound-healing compositions containing iodine and a non-reducing sugar
11/29/1995EP0683660A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995EP0586523A4 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/29/1995CN1112786A 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
11/29/1995CN1112560A Piperidine derivatives and anti-platelet agents containing the same
11/29/1995CN1112442A Baicaoshengshou oral liquor and its preparation
11/29/1995CN1112420A Orally administerable pharmaceutical formulations
11/29/1995CN1112416A Cosmetic or pharmaceutical compositions consisting of liposomes
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470882 Diphenylsulfide with urea and sulfonates
11/28/1995US5470861 Method of promoting hair growth
11/28/1995US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use
11/28/1995US5470844 Heterocyclic-NMDA antagonists
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470831 Angiogenic peptides
11/28/1995CA2150334A1 L-lysyl-glycyl-l-histidine and therapeutic agent for wound healing containing the same
11/28/1995CA2091986C Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
11/28/1995CA1337660C Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
11/28/1995CA1337654C Fused tricyclic lactams as antihypertensive agents
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031455A1 Quinolinecarboxylic acid derivative
11/23/1995WO1995031451A1 Novel compounds
11/23/1995WO1995031437A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
11/23/1995WO1995031205A1 Sialic acid/fucose based medicaments
11/23/1995WO1995031203A1 Oral liquid alendronate formulations
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995WO1995031195A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2167055A1 Quinolinecarboxylic acid derivative
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995EP0683170A1 Glucopyranoside benzothiophenes
11/22/1995EP0683168A1 Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine
11/22/1995EP0683166A1 3-Indolylpiperidines
11/22/1995EP0683156A1 Acylated aminoalkanimidazoles and -triazoles
11/22/1995EP0683155A1 Tetrahydrobenz cd indoles with serotonin regulatory activity
11/22/1995EP0682878A2 Nutrition
11/22/1995EP0682869A1 Non-systemic control of parasites
11/22/1995EP0682664A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
11/22/1995EP0682663A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections
11/22/1995EP0682656A1 Use of phenyl heteroaryl ureas as 5ht 2c? receptor antagonists and urea compounds
11/22/1995EP0682654A1 Benzo-fused lactams promote release of growth hormone
11/22/1995EP0682514A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
11/22/1995EP0544714B1 Heterocyclic compounds and their preparation and use
11/22/1995CN1112122A Sulfated-glycolipid derivatives as cell adhesion inhibitors
11/22/1995CN1112117A Imidazole-containing inhibitors of farnesyl protein transferase
11/22/1995CN1112114A Novel aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and the pharmaceutical compositions which contain them
11/22/1995CN1112112A New bicyclic derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
11/22/1995CN1112111A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
11/22/1995CN1111986A Isoxazole derivatives for the treatment of irritable bowels syndrome
11/21/1995US5468882 Serotoninergic agents; central nervous system and psychological disorders
11/21/1995US5468867 Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
11/21/1995US5468764 Administering to a mammal an azole derivative
11/21/1995US5468757 For treating stroke or myocardial infarction in humans
11/21/1995US5468736 Hormone replacement therapy
11/21/1995US5468505 Local delivery of fibrinolysis enhancing agents
11/21/1995US5468472 Topical process for lightening the skin or treating pigmental blemishes using a composition containing 4-thioresorcin derivatives
11/21/1995CA2149501A1 Glucopyranoside benzothiophenes
11/21/1995CA1337604C Phospholipid complexes of extract of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them
11/19/1995CA2149608A1 Tetrahydrobenz¬cd|indazoles
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists
11/16/1995WO1995030673A1 Anti-cancer compounds containing cyclopentaquinazoline ring
11/16/1995WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
11/16/1995WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents
11/16/1995WO1995030435A2 Compositions and treatment for multiple sclerosis
11/16/1995WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995030421A1 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
11/16/1995WO1995030417A1 Potentiated antibiotic composition
11/16/1995WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995CA2189990A1 Compositions and treatment for multiple sclerosis
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/15/1995EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds
11/15/1995EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
1 ... 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 ... 1564